AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 237 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,963 | -97.5% | 96,684 | +1676.0% | 0.05% | +1533.3% |
| Q3 2022 | $243,000 | -49.5% | 5,444 | -53.2% | 0.00% | -50.0% |
| Q1 2022 | $481,000 | -84.1% | 11,627 | -68.4% | 0.01% | -92.4% |
| Q2 2020 | $3,028,000 | +441.7% | 36,804 | +69.6% | 0.08% | +259.1% |
| Q2 2019 | $559,000 | -37.4% | 21,703 | -65.4% | 0.02% | -67.2% |
| Q1 2019 | $893,000 | – | 62,772 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |